TGR BioSciences brings novel, commercially successful high throughput cell-based screening platform technologies to Australian researchers. TGR is a successful SME, providing protein bioactive detection capabilities that are also now utilized by most major international pharmaceutical organisations and a number of centres of research excellence globally. This approach to functional proteomics, where activity is paramount to protein isolation, complements traditional protein identification at other nodes within the new PA’s services portfolio. The inclusion of TGR within PA addresses the growth segment of “bioactives”, ensuring Australia maintains competitive leadership in this emerging market.